Medivir AB (publ)
MVRBF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $4,408 | $25,538 | $13,948 | $8,724 |
| % Growth | -82.7% | 83.1% | 59.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $4,408 | $25,538 | $13,948 | $8,724 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $73,277 | $52,932 | $91,063 |
| SG&A Expenses | $0 | $73,277 | $52,932 | $91,063 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $10,139 | $0 |
| Operating Expenses | $93,016 | $89,938 | $69,632 | $134,703 |
| Operating Income | -$87,354 | -$62,118 | -$42,900 | -$125,979 |
| % Margin | -1,981.7% | -243.2% | -307.6% | -1,444.1% |
| Other Income/Exp. Net | -$1,411 | -$461 | $280 | $2,645 |
| Pre-Tax Income | -$88,765 | -$62,579 | -$42,620 | -$123,334 |
| Tax Expense | $0 | $546 | $0 | $106 |
| Net Income | -$88,765 | -$63,125 | -$42,620 | -$123,440 |
| % Margin | -2,013.7% | -247.2% | -305.6% | -1,414.9% |
| EPS | -1.59 | -1.2 | -1.44 | -4.17 |
| % Growth | -32.5% | 16.7% | 65.5% | – |
| EPS Diluted | -1.59 | -1.2 | -1.44 | -4.17 |
| Weighted Avg Shares Out | 55,736 | 52,815 | 29,580 | 29,580 |
| Weighted Avg Shares Out Dil | 55,736 | 52,815 | 29,580 | 29,580 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8 | $0 | $1 | $1,361 |
| Interest Expense | $928 | $950 | $547 | $1,315 |
| Depreciation & Amortization | $2,571 | $2,595 | $4,430 | $7,086 |
| EBITDA | -$85,266 | -$59,034 | -$37,643 | -$114,933 |
| % Margin | -1,934.3% | -231.2% | -269.9% | -1,317.4% |